Arcturus Therapeutics Holdin

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$13.02

-0.19 (-1.44%)

As of Oct 3, 2:18 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 78%

Hold 4 22%

Sell 0 0%

Price Target

Analyst Price Target +102.8% upside

Low Target $16.23

Average Target $26.41

High Target $33.18

Current Price $13.02

Current
$13.02

Target
$26.41

$16.23 $26.41 avg $33.18

Scenario Analysis

Bear Case

$16.23

24.7%

Low target

Base Case

$26.41

+102.8%

Avg target

Bull Case

$33.18

+154.8%

High target

Risk/Reward

6.3x

Highly favorable

Price in Context

52-Week High

$24.17

-46.1% from high

52-Week Low

$5.50

+136.7% from low

Target vs 52W High

$26.41

+9.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.0%
AMGN Amgen Inc	Hold	43	47%	$190.87	-52.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+150.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-13.2%
MRNA Moderna Inc	Hold	30	37%	$149.45	-21.3%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.8%